Balance Sheet Components

12 Months Ended

Dec. 31, 2024

Balance Sheet Components

Balance Sheet Components

8. Balance Sheet Components (in thousands):

	December 31,
	2024		2023
Prepaid and Other Current Assets
Interest receivable	$	141	$	37
Prepaid research and development manufacturing expenses		1,209		149
Prepaid facility expenses		308		196
Prepaid insurance		162		179
Other		548		220
	$	2,368	$	781
Property and Equipment
Laboratory equipment	$	2,522	$	2,678
Computer equipment and purchased software		171		171
Leasehold improvements		2,084		2,084
		4,777		4,933
Less: accumulated depreciation and amortization		(4,626)		(4,697)
	$	151	$	236
Accrued and Other Liabilities
Accrued clinical trial expense	$	1,672	$	2,302
Accrued manufacturing expense		679		675
Personnel related		820		684
Accrued legal and accounting		265		64
Other		289		245
	$	3,725	$	3,970

During the years ended December 31, 2024, 2023, and 2022, the Company recorded $0.1 million, $0.2 million and $0.4 million in depreciation expense, respectively.